The routine use of cross-sectional imaging has resulted in a significant increase in the age-adjusted incidence of renal cell carcinoma (RCC). However, this has not translated into a decrease in cancer specific deaths, suggesting the possible over treatment of small, potentially indolent renal tumors. Thus, active surveillance of RCC has been proposed for small tumors. However, the natural history of these tumors remains unknown. Angiogenesis and tumor necrosis correlate with prognosis and metastatic potential in RCC. Inactivation of the VHL gene, HIF upregulation, and VEGF over- expression form the molecular basis of the enhanced angiogenesis associated with RCC. Arterial spin labeling (ASL) is a magnetic resonance imaging (MRI) method for measuring blood flow by manipulating the signal from inflowing arterial blood. ASL blood flow correlates tightly to vascularity in RCC. The apparent diffusion coefficient (ADC) in RCC, measured with diffusion-weighted imaging (DWI), correlates with tumor cellularity at pathology. We seek to identify vascular and diffusion MRI measures in RCC in vivo that correlate to spatially-co-registered molecular alterations promoting angiogenesis and hypoxia and predict aggressive behavior. The spatial synchronization of various tissue-based analyses with in vivo alterations in tumor perfusion and hypoxia may help develop more robust imaging biomarkers to predict the biologic behavior of RCC. If successful, these imaging biomarkers will be immediately applicable to clinical practice and will help selecting patients for active surveillance.
The aim of the proposed research is to investigate the correlation between in vivo magnetic resonance imaging (MRI) measures of blood flow and cellularity with the molecular alterations that promote angiogenesis and necrosis in renal cell carcinoma (RCC) and to correlate these to the biologic behavior of these tumors. Quantitative measures of blood flow and cellularity will be obtained with arterial spin labeling (ASL) and diffusion weighted imaging (DWI), respectively.
|Yokoo, Takeshi; Clark, Haley R; Pedrosa, Ivan et al. (2016) Quantification of renal steatosis in type II diabetes mellitus using dixon-based MRI. J Magn Reson Imaging 44:1312-1319|
|Yuan, Qing; Kapur, Payal; Zhang, Yue et al. (2016) Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity. Clin Genitourin Cancer :|
|Zhang, Yue; Kapur, Payal; Yuan, Qing et al. (2016) Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clin Genitourin Cancer 14:e25-36|
|Hannan, Raquibul; Margulis, Vitaly; Chun, Stephen G et al. (2015) Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus. Cancer Biol Ther 16:657-61|
|Durinck, Steffen; Stawiski, Eric W; PavÃa-JimÃ©nez, Andrea et al. (2015) Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet 47:13-21|
|Moore, William A; Khatri, Gaurav; Madhuranthakam, Ananth J et al. (2014) Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis. AJR Am J Roentgenol 202:995-1006|
|Campbell, Naomi; Rosenkrantz, Andrew B; Pedrosa, Ivan (2014) MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging 23:95-115|
|Madhuranthakam, Ananth J; Lee, Karen S; Yassin, Aya et al. (2014) Improved short tau inversion recovery (iSTIR) for increased tumor conspicuity in the abdomen. MAGMA 27:245-55|
|Beddy, Peter; Genega, Elizabeth M; Ngo, Long et al. (2014) Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer 12:55-62|
|Wang, Shan-Shan; Gu, Yi-Feng; Wolff, Nicholas et al. (2014) Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proc Natl Acad Sci U S A 111:16538-43|
Showing the most recent 10 out of 13 publications